Effects of secnidazole-diminazene aceturate combination therapy on parasitaemia and serum biochemical profile after late treatment in Trypanosoma brucei brucei infected dogs
Relapse parasitaemia is a major setback in the chemotherapy of a late stage Trypanosoma brucei brucei infection. An aberrant serum biochemical profile resulting from a T. b. brucei infection in dogs has been attributed to multiple organ injuries resulting from the invasive nature of the organism. Therapy with diminazene aceturate alone has not been satisfactory. This study evaluated the effects of a secnidazole-diminazine aceturate (SEC-DA) combination therapy on parasitaemia and the serum biochemical profile after the late treatment of a T. b. brucei infection in dogs. Eighteen dogs were randomly assigned to 6 groups (n = 3) as follows: Group A: uninfected nor treated; group B: infected without treatment; group C: infected and treated with DA (3.5 mg/kg) (DA-monotherapy) intramuscularly (i.m.) once; group D: infected and treated with SEC (100 mg/kg) and DA (3.5 mg/kg); group E: in-fected and treated with SEC (200 mg/kg) and DA (3.5 mg/kg) and group F: infected and treated with SEC (400 mg/kg) and DA (3.5 mg/kg). Secnidazole was administered orally for 5 days while DA was given i.m. once in groups D–F. The dogs were infected with 5 × 105 trypanosomes intraperitoneally and treatment started 14 days post-infection. The parasitaemia was monitored daily while the serum biochemical indicators were monitored 14, 21, and 28 days post-infection. The total aparasitaemia was achieved in the SEC-DA treated dogs 72 h post-treatment and in 86 h in the DA-monotherapy dogs. A relapse parasitaemia occurred in the DA-monotherapy dogs 17 days post-treatment. The SEC-DA combination therapy caused a significant (P < 0.05) decline in the hitherto elevated urea and creatinine concentrations, and the ALP, ALT, AST activities. Also, there was a significant (P < 0.05) increase in the previously decreased serum albumin in the SEC-DA treated dogs. In conclusion, secnidazole-diminazene aceturate combination therapy prevented the relapse parasitaemia and ameliorated aberrant serum biochemical profiles of T. b. brucei infected dogs after late treatment.
Abenga JN, Anosa VO. Serum biochemical changes in experimental gambian trypanosomosis. II. Assessing hepatic and renal dysfunction. Turk J Vet Anim Sci. 2007 Nov 28;31(5):293-6.
Adamu S, Barde N, Abenga JN, Useh NM, Ibrahim ND, Esievo KA. Experimental Trypanosoma brucei infection-induced changes in the serum profiles of lipids and cholesterol and the clinical implications in pigs. J Cell Anim Biol. 2009 Feb;3(2):15-20.
Akpa PO, Ezeokonkwo RC, Eze CA, Anene BM. Comparative efficacy assessment of pentamidine isethionate and diminazene aceturate in the chemotherapy of Trypanosoma brucei brucei infection in dogs. Vet Parasitol. 2008 Feb 14;151(2-4):139-49. https://doi.org/10.1016/j.vetpar.2007.10.024
Allam L, Ogwu D, Agbede RI, Sackey AK. Hematological and serum biochemical changes in gilts experimentally infected with Trypanosoma brucei. Vet Arh. 2011 Oct 20;81(5):597-609.
American Liver Foundation. Liver function tests [Internet]. 2017 [cited Aug 4, 2019]. [New York]. Available from www.liverfoundation.org/for-patients/about-the-liver/the-progression-of-liver-disease/diagnosing-liver-disease/.
Anene BM, Chukwu CC, Anika SM. Immunosuppression of humoral immune response in canine trypanosomiasis. Microbios Lett. 1989;40(157):37-46.
Biryomumaisho S, Katunguka-Rwakishaya E, Rubaire-Akiiki CM. Serum biochemical changes in experimental Trypanosoma congolense and Trypanosoma brucei infection in Small East Africa goats. Vet Arh. 2003 Jun 22;73(3):167-80.
Eke IG, Eze IO, Ezeudu TA, Eze UU, Anaga AO, Onyeyili PA. Anti-trypanosomal activity of secnidazole in vitro and in vivo. Trop J Pharm Res. 2017a;16(3):535-41. https://doi.org/10.4314/tjpr.v16i3.6
Eke IG, Eze UU, Ezeudu TA, Ezeh IO, Anaga AO, Onyeyili PA. Diminazene aceturate residues in tissues of dogs treated with secnidazole-diminazene aceturate combination and with diminazene aceturate alone. Sokoto J Vet Sci. 2017b;15(4):16-20. https://doi.org/10.4314/sokjvs.v15i4.3
Eke IG, Ezeh IO, Ezeudu TA, Eze UU, Anaga AO, Onyeyili PA. Efficacy of secnidazole-diminazene aceturate combination therapy in the late treatment of Trypanosoma brucei brucei infection in dogs. Braz J Pharm Sci. 2020;56:1-8. https://doi.org/10.1590/s2175-97902019000318042
Eloy LJ, Lucheis SB. Canine trypanosomiasis: Etiology of infection and implications for public health. J Venom Anim Toxins Incl Trop Dis. 2009;15(4):589-611. https://doi.org/10.1590/S1678-91992009000400002
Ezeokonkwo RC, Ezeh IO, Onunkwo JI, Onyenwe IW, Iheagwam CN, Agu WE. Comparative serum biochemical changes in mongrel dogs following single and mixed infections of Trypanosoma congolense and Trypanosoma brucei brucei. Vet Parasitol. 2012 Nov 23;190(1-2):56-61. https://doi.org/10.1016/j.vetpar.2012.05.012
Herbert WJ, Lumsden WH. Trypanosoma brucei: A rapid “matching” method for estimating the host’s parasitemia. Exp Parasitol. 1976 Dec;40(3):427-31. https://doi.org/10.1016/0014-4894(76)90110-7
Jennings FW, Whitelaw DD, Urquhart GM. The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapy. Parasitology. 1977 Oct;75(2):143-53. https://doi.org/10.1017/S0031182000062284
Nwoha RI, Eze IO, Anene BM. Serum biochemical and liver enzymes changes in dogs with single and conjunct experimental infections of Trypanosoma brucei and Ancylostoma caninum. Afr J Biotechnol. 2013;12(6):618-24.
Nwoha RIO, Anene BM. Comparative assessment of dogs experimentally infected with single Trypanosoma brucei, Ancylostoma caninum and conjunct Trypanosoma brucei and Ancylostoma caninum infections and treated with diminazene aceturate and mebendazole. Int J Trop Dis Health. 2016;12(1):1-10. https://doi.org/10.9734/IJTDH/2016/21722
Nwosu CO, Ikeme MM. Parasitaemia and clinical manifestations in Trypanosoma brucei infected dogs. Rev Elev Med Vet Pays Trop. 1992;45(3-4):273-7.
OIE – Office International des Epizootics. Manual of diagnostic tests and vaccines for terrestrial animals. Paris: Office International des Epizooties; 2008. 6th ed. p. 353-4.
Onyeyili PA, Anika SM. Chemotherapy of T. b. brucei infection: Use of DFMO, diminazene aceturate, alone and in combination. J Small Anim Prac. 1989 Sep;30(9):505-10. https://doi.org/10.1111/j.1748-5827.1989.tb01621.x
Onyeyili PA, Egwu GO. Chemotherapy of African trypanosomiasis: A historical perspective. Protozoological Abstracts. 1995;19(5):230-41.
Rode AM, Bijwal DL, Bhojne GR, Chopde SS, Shrikhande GB. Biochemical profile in trypanosomiasis of dogs. IJVSBT. 2009;5(1):27-9.
Rouzer CA, Cerami A. Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: Role of defective triglyceride removal. Mol Biochem Parasitol. 1980 Oct;2(1):31-8. https://doi.org/10.1016/0166-6851(80)90046-8
Samra M, Abcar AC. False estimates of elevated creatinine. Perm J. 2012 Spring;16(2):51-2. https://doi.org/10.7812/TPP/11-121
Takeet MI, Fagbemi BO. Haematological, pathological and plasma biochemical changes in rabbits experimentally infected with Trypanosoma congolense. Sci World J. 2009;4(2):29-36.